Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Arginine and Omega-N-Methylarginine

Research Papers that Mention the Interaction

Infusion of L‐NMMA resulted in a maximum venodilation of 38% ± 11% ( R ) versus 10% ± 5% (NR; P = .005).
Journal of clinical pharmacology  •  2012  |  View Paper
The prolonged effect of L-NMMA and L-arginine must be taken into account in study protocols using both substances.
American journal of hypertension  •  2002  |  View Paper
All hemodynamic effects of L-NMMA were reversed by L-arginine.
The American journal of physiology  •  1999  |  View Paper
L-Arginine (10(-3) mol/L) prevented the contractions by L-NMMA and ADMA but did not change contractions induced by AG and MG.
Stroke  •  1999  |  View Paper
The coinfusion with L-arginine caused a nearly two-fold increase in plasma L-NMMA levels, indicating a pharmacokinetic interaction.
British journal of clinical pharmacology  •  1999  |  View Paper
The mean BP significantly increased during infusion of L-NMMA (control 97.0 +/- 5.7 vs. L-NMMA 4.0 mumol/min: 116.4 +/- 3.1 mm Hg) and this was also reversed by L-arg.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society  •  1997  |  View Paper
L-Arginine alone failed to affect basal or stimulated (CCK or yolk) emptying of the GB, but when combined with L-NMMA , it reversed the enhancement of GB contraction caused by L-NMMA.
Digestion  •  1997  |  View Paper
When added at the apical side, the NOS‐inhibitors NMMA and NIL, CAA analogs with a free carboxyl group, markedly inhibited the apical arginine influx and the transepithelial flux of the cationic amino acid.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology  •  2005  |  View Paper
Pretreatment with l‐NMMA caused a prompt drop in myeloperoxidase (MPO) activity, suggesting rapid adhesion of PMNL to the coronary wall; this effect was significantly blunted by l‐arginine.
Pretreatment with l‐NMMA , caused a marked rise in cys‐LT concentrations which was prevented by l‐arginine.
NG‐monomethyl‐l‐arginine , 10 μm (l‐NMMA), induced a marked increase in CPP (290±40 mmHg, at 20 min) and in … it caused cardiac arrest in systole in 5 out of 6 hearts and these were prevented by l‐arginine , 100 μm (CPP 115±… mmHg, at 30 min).
British journal of pharmacology  •  1997  |  View Paper
Furthermore, l‐NMMA also reversed the dilatation already induced by PACAP and excess concentrations of l‐arginine restored the dilator response of the l‐NMMA treated arteries.
British journal of pharmacology  •  1997  |  View Paper
Show More